DalsnaFinance › IPOs › Zentalis Pharmaceuticals › IPO
Zentalis Pharmaceuticals, Inc. completed its initial public offering on NASDAQ on April 3, 2020, pricing at $18.00 a share.
| Ticker | ZNTL |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | April 3, 2020 |
| Offering price | $18.00 |
| Shares offered | 9,180,000 |
| Total raised | $165M |
Zentalis Pharmaceuticals, Inc. sold 9,180,000 shares at $18.00 each on NASDAQ. Multiplied out, that is $165.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $165 million total recorded for the deal.
Zentalis Pharmaceuticals, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Zentalis Pharmaceuticals, Inc.. This page is general information, not investment advice.